2120. thioguanine in the treatment of certain autoimmune, immunologic andrelated diseasesthe therapeutic effectiveness of 6-thioguanine has been evaluated over the past3 years in 19 patients with diverse syndromes.  only patients with severedebilitating disease unresponsive to conventional therapy were treated.remissions occurred in 2 of 5 patients with systemic lupus erythematosus, in 1patient each with dermatomyositis and necrotizing angiitis, 2 patients withpsoriasis and 2 of 4 patients with atopic disease.  improvement occurred inother patients with these diseases and in 2 of 4 patients withneurodermatitis.  two patients with scleroderma experienced onlyequivocal benefit.  significant toxicity attributable to the drugwas observed in 5 patients.  assessment of the eventual value ofthese agents in therapy requires further study.  hypotheses regarding themechanism of action of these agents and the significance of clinicalresponse are discussed.